cis-Diammineplatinum dichloride - Moligand™, Pt,65% , CAS No.15663-27-1

CAS: 15663-27-1 Cat. No.: D109812 Peso molecular: 300.1 Número EC: 239-733-8

GRADE & PURITY Moligand™, Pt,65%

Synonyms

Cisplatin

Storage

Protected from light,Room temperature,Argon charged,Desiccated,Cool

Shipped In

Normal

Specifications

Sinónimos

Cisplatin

Especificaciones y pureza

Moligand™, Pt, 65%

Mecanismos bioquímicos y fisiológicos

Forms cytotoxic adducts with the DNA dinucleotide d(pGpG), inducing intrastrand cross-links.Potent, broad spectrum antineoplastic agent. Cytotoxic, crosslinks DNA to impair replication and transcription. Arrests cell cycle in G 2 /M phase. Antitumor, cros

Condiciones de almacenamiento de almacenamiento

Protected from light, Room temperature, Argon charged, Desiccated, Cool

Enviado en

Normal

Grado

Moligand™

Nota

Unstable; make up solutions fresh and use immediately. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Nombres e identificadores

• Sonrisas canónicas: N.N.Cl[Pt]Cl
• InChIKey: LXZZYRPGZAFOLE-UHFFFAOYSA-L
• INCHI: 1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2
• WGK Alemania: 3
• RTECS: TP2450000
• Número ONU: 2928
• Grupo de embalaje: I
• Peso molecular: 300.1

Taxonomic Classification

Taxonomy Tree

• Kingdom Inorganic compounds
  • Superclass Mixed metal/non-metal compounds
    • Clase Transition metal salts
      • Subclass Transition metal chlorides

• Kingdom: Inorganic compounds
• Superclass: Mixed metal/non-metal compounds
• Clase: Transition metal salts
• Subclass: Transition metal chlorides
• Intermediate Tree Nodes: Not available
• Direct Parent: Transition metal chlorides
• Alternative Parents: Inorganic chloride salts
• Molecular Framework: Not available
• Substituents: Transition metal chloride - Inorganic chloride salt - Inorganic salt
• Descripción: This compound belongs to the class of inorganic compounds known as transition metal chlorides. These are inorganic compounds in which the largest halogen atom is Chlorine, and the heaviest metal atom is a transition metal.
• External Descriptors: diamminedichloroplatinum

Data sources

1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.

DOI: 10.1186/s13321-016-0174-y

Propiedades químicas y físicas

• Solubilidad: Soluble in DMSO (25 mg/ml), water (0.25 g/100ml) at 25 °C, ethanol (<1 mg/ml) at 25 °C, and DMF (16 mg/ml)
• Sensibilidad: Moisture sensitive & Light sensitive
• Punto de fusión (°C): 270°C

Referencias

1. Jiang Hao, Tian Hailong, Wang Zhihan, Li Bowen, Chen Rui, Luo Kangjia, Lu Shuaijun, Nice Edouard C., Zhang Wei, Huang Canhua, Zhou Yuping, Zheng Shaojiang, Gao Feng.  (2023)  Laser-activatable oxygen self-supplying nanoplatform for efficiently overcoming colorectal cancer resistance by enhanced ferroptosis and alleviated hypoxic microenvironment.  Biomaterials Research,  27  (1): (1-20).  [PMID:37742011] [10.1186/s40824-023-00427-1]

2. Leyi Fang, Xiao-Tong Pan, Kang Liu, Dechen Jiang, Deju Ye, Li-Na Ji, Kang Wang, Xing-Hua Xia.  (2023)  Surface-Roughened SERS-Active Single Silver Nanowire for Simultaneous Detection of Intracellular and Extracellular pHs.  ACS Applied Materials & Interfaces,      [PMID:37071781] [10.1021/acsami.3c00844]

3. Yunfan Liu, Jiazhou Zhai, Fei Qin, Liping Gao, Yongxin She, Mengqiang Wang.  (2023)  Protective role of polyphenol extract from highland barley against cisplatin-induced renal toxicity and mitochondrial damage in rats.  FOOD SCIENCE AND TECHNOLOGY RESEARCH,      [PMID:] [10.3136/fstr.FSTR-D-21-00284]

4. Yi Xiao, Haomin Yi, Jingzhi Zhu, Suhua Chen, Guofang Wang, Yilong Liao, Yuanyuan Lei, Liyin Chen, Xingcai Zhang, Fangfu Ye.  (2022)  Evaluation of DNA adduct damage using G-quadruplex-based DNAzyme.  Bioactive Materials,      [PMID:36406255] [10.1016/j.bioactmat.2022.10.002]

5. Zhou Yafu, Yan Jianhua, Chen Huiguo, Zhou Wenwu, Yang Jinsong.  (2022)  MicroRNA-133a-3p Inhibits Lung Adenocarcinoma Development and Cisplatin Resistance through Targeting GINS4.  CELLS TISSUES ORGANS,      [PMID:36273455] [10.1159/000527684]

6. Xue-qi Liu, Ming-ming Liu, Ling Jiang, Li Gao, Yao Zhang, Yue-bo Huang, Xian Wang, Wei Zhu, Han-xu Zeng, Xiao-ming Meng, Yong-gui Wu.  (2022)  A novel small molecule Hsp90 inhibitor, C-316-1, attenuates acute kidney injury by suppressing RIPK1-mediated inflammation and necroptosis.  INTERNATIONAL IMMUNOPHARMACOLOGY,      [PMID:35588657] [10.1016/j.intimp.2022.108849]

7. Yaodong Yi, Liping Li, Feifeng Song, Ping Li, Mingyang Chen, Shixin Ni, Hengbin Zhang, Hui Zhou, Su Zeng, Huidi Jiang.  (2021)  L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity.  TOXICOLOGY,      [PMID:34252480] [10.1016/j.tox.2021.152853]

8. Liuwei Zhang, Ming Qian, Hongyan Cui, Shuang Zeng, Jingyun Wang, Qixian Chen.  (2021)  Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.  ACS Applied Materials & Interfaces,      [PMID:33525873] [10.1021/acsami.0c21422]

9. Zheng Di-Wei, Pan Pei, Chen Ke-Wei, Fan Jin-Xuan, Li Chu-Xin, Cheng Han, Zhang Xian-Zheng.  (2020)  An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure.  Nature Biomedical Engineering,  4  (9): (853-862).  [PMID:32632226] [10.1038/s41551-020-0582-1]

10. Cui Li, Liping Li, Yaodong Yi, Wei Wang, Jingqun Yuan, Fuqing Tan, Danbo Fang, Su Zeng, Hui Zhou, Huidi Jiang.  (2020)  L-tetrahydropalmatine attenuates cisplatin-induced nephrotoxicity via selective inhibition of organic cation transporter 2 without impairing its antitumor efficacy.  BIOCHEMICAL PHARMACOLOGY,      [PMID:32389634] [10.1016/j.bcp.2020.114021]

11. Peng-Chao Zhang, Xiao Liu, Man-Mei Li, Yan-Yan Ma, Hong-Tao Sun, Xu-Yan Tian, Yan Wang, Min Liu, Liang-Shun Fu, Yi-Fei Wang, Hong-Yuan Chen, Zhong Liu.  (2019)  AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo.  BIOCHEMICAL PHARMACOLOGY,      [PMID:31863779] [10.1016/j.bcp.2019.113771]

12. Chen Xiao, Hang Hu, Hai Yang, Si Li, Hui Zhou, Jian Ruan, Yuting Zhu, Xiangliang Yang, Zifu Li.  (2018)  Colloidal hydroxyethyl starch for tumor-targeted platinum delivery.  Nanoscale Advances,  1  (3): (1002-1012).  [PMID:36133197] [10.1039/C8NA00271A]

13. Guangjian Zeng, Meiying Liu, Ruming Jiang, Chunning Heng, Qiang Huang, Liucheng Mao, Junfeng Hui, Fengjie Deng, Xiaoyong Zhang, Yen Wei.  (2017)  Surface grafting of Eu3 + doped luminescent hydroxyapatite nanomaterials through metal free light initiated atom transfer radical polymerization for theranostic applications.  Materials Science & Engineering C-Materials for Biological Applications,      [PMID:28532048] [10.1016/j.msec.2017.03.261]

14. Xiangxiang Liu, Bowei Liu, Sijia Gao, Zhaocheng Wang, Ye Tian, Man Wu, Shidong Jiang, Zhongwei Niu.  (2017)  Glyco-decorated tobacco mosaic virus as a vector for cisplatin delivery.  Journal of Materials Chemistry B,  5  (11): (2078-2085).  [PMID:32263681] [10.1039/C7TB00100B]

15. Huang Wuren, Zhang Jie, Yang Bing, Beerntsen Brenda T., Song Hongsheng, Ling Erjun.  (2016)  DNA duplication is essential for the repair of gastrointestinal perforation in the insect midgut.  Scientific Reports,  6  (1): (1-10).  [PMID:26754166] [10.1038/srep19142]

16. Xiali Yin, Yaohua Ke, Ying Liang, Shuxian Zhang, Ziqi Chen, Lixia Yu, Ming Jiang, Qin Liu, Xiaoping Gu.  (2024)  An Immune-Enhancing Injectable Hydrogel Loaded with Esketamine and DDP Promotes Painless Immunochemotherapy to Inhibit Breast Cancer Growth.  Advanced Healthcare Materials,      [PMID:39118566] [10.1002/adhm.202401373]

17. Keli Liu, Shaofan Hu, Reziyamu Wufuer, Qun Zhang, Lu Qiu, Zhengwen Zhang, Meng Wang, Yiguo Zhang.  (2025)  Deficiency of DDI2 suppresses liver cancer progression by worsening cell survival conditions.  FREE RADICAL BIOLOGY AND MEDICINE,      [PMID:40049338] [10.1016/j.freeradbiomed.2025.03.003]

18. Reziyamu Wufuer, Keli Liu, Jing Feng, Meng Wang, Shaofan Hu, Feilong Chen, Shanshan Lin, Yiguo Zhang.  (2024)  Distinct mechanisms by which Nrf1 and Nrf2 as drug targets contribute to the anticancer efficacy of cisplatin on hepatoma cells.  FREE RADICAL BIOLOGY AND MEDICINE,      [PMID:] [10.1016/j.freeradbiomed.2024.01.031]

19. Lele Xu, Yuting Chen, Tao Wu, Jiaqi Fan, Yuying Hu, Xuefeng Gao, Yuliang Wang, Tao Chen, Xueting Zhao, Min Zeng, Fei Wang, Qingyou Zheng, Xiaojuan Pei, Dinglan Wu.  (2024)  DNA damage-mediated FTO downregulation promotes CRPC progression by inhibiting FOXO3a via an m6A-dependent mechanism.  iScience,      [PMID:39238652] [10.1016/j.isci.2024.110505]

20. Wu Yuanlin, Zhang Jiandong, Zhao Junjun, Wang Bin.  (2024)  Folate-modified liposomes mediate the co-delivery of cisplatin with miR-219a-5p for the targeted treatment of cisplatin-resistant lung cancer.  BMC Pulmonary Medicine,  24  (1): (1-14).  [PMID:38561695] [10.1186/s12890-024-02938-6]

21. Lujuan Han, Xiaohan Xiang, Yuhui Fu, Sisi Wei, Cong Zhang, Lei Li, Yueping Liu, Huilai Lv, Lianmei Zhao, Baoen Shan.  (2024)  Periplcymarin targets glycolysis and mitochondrial oxidative phosphorylation of esophageal squamous cell carcinoma: Implication in anti-cancer therapy.  PHYTOMEDICINE,      [PMID:38522311] [10.1016/j.phymed.2024.155539]

22. Zou Lan, Wang Rujing, Zhao Mengnan, Li Yuke, Sun Chen, Xie Jinjin, Chen Yan, Jing Qian, Mi Dandan, Shi Sanjun.  (2025)  PLGA confers upon conventional nonfluorescent molecules luminescent properties to trigger 1O2-induced pyroptosis and immune response in tumors.  JOURNAL OF NANOBIOTECHNOLOGY,  23  (1): (1-23).  [PMID:39844156] [10.1186/s12951-025-03094-7]

23. Song Zeyu, Li Zhenyuan, Pan Tao, Liu Teng, Gong Baifang, Wang Zhixia, Liu Ke, Fan Huaying.  (2024)  Protopanaxadiol prevents cisplatin-induced acute kidney injury by regulating ferroptosis.  JOURNAL OF PHARMACY AND PHARMACOLOGY,      [PMID:38708970] [10.1093/jpp/rgae050]

24. Yuru Pang, Qiqi Meng, Yangchen Cui, Shiyi Liu, Huihui Jiang, Chenlan Xu, Yan An, Yang Jiao, Qi Zhang, Jihua Nie.  (2025)  Radiosensitization effect of iridium (III) complex on lung cancer cells via mitochondria apoptosis pathway.  Frontiers in Pharmacology,      [PMID:40230690] [10.3389/fphar.2025.1562228]

25. Sui Xue, Gao Bingqing, Zhang Liu, Wang Yanmin, Ma Junnan, Wu Xingchen, Zhou Chenyu, Liu Min, Zhang Lin.  (2024)  Scutellaria barbata D.Don and Hedyotis diffusa Willd herb pair combined with cisplatin synergistically inhibits ovarian cancer progression through modulating oxidative stress via NRF2-FTH1 autophagic degradation pathway.  Journal of Ovarian Research,  17  (1): (1-17).  [PMID:39702302] [10.1186/s13048-024-01570-6]

26. Tang Wei, Zong Shimin, Du Peiyu, Yu Xuan, Li Ting, Liu Bo, Zhong Yu, Lei Wenyang, Yu Wenting, Xiao Hongjun.  (2025)  SIRT3 regulates PFKFB3-mediated glycolysis to attenuate cisplatin-induced ototoxicity both in vivo and in vitro.  ARCHIVES OF TOXICOLOGY,      [PMID:39945816] [10.1007/s00204-025-03975-8]

27. Borui Zhao, Xuan Qin, Rui Fu, Maosen Yang, Xin Hu, Shaorong Zhao, Yange Cui, Qingxiang Guo, Wei Zhou.  (2024)  Supramolecular nanodrug targeting CDK4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma.  JOURNAL OF CONTROLLED RELEASE,      [PMID:38479445] [10.1016/j.jconrel.2024.03.014]

28. Li Xiaoli, Wang Jiashuo, Guo Jiaxing, Zhang Ming.  (2025)  Targeting TNFAIP2 with NIR-II CRISPR-Cas9 nanosystem to overcome cisplatin resistance in laryngeal cancer.  npj Precision Oncology,  9  (1): (1-21).  [PMID:40731142] [10.1038/s41698-025-01054-w]

29. Ziqi Chen, Yaohua Ke, Junmeng Zhu, Lanqi Cen, Wenmei Rao, Sen Hong, Yan Wang, Jie Shao, Yanhong Chu, Xiaoping Qian, Baorui Liu, Rutian Li, Qin Liu.  (2025)  Biomineralized engineered Lactococcus lactis-based in situ vaccination enhances antitumor immunity via sequential activation of chemo-immunotherapy.  Journal for ImmunoTherapy of Cancer,  13  (8): (e011799).  [PMID:40819921] [10.1136/jitc-2025-011799]

30. Wei Zhu, Sai Zhu, Shan Jiang, Jiuyu Yin, Yonggui Wu, Xiaomei Luo.  (2025)  Paeoniflorin alleviates necroptosis in acute kidney injury induced by cisplatin and lansoprazole through targeting TNFAIP3.  INTERNATIONAL IMMUNOPHARMACOLOGY,      [PMID:40779843] [10.1016/j.intimp.2025.115340]

31. Lu Jin, Yuanquan Ran, Nian Yang, Lanlan Yang, Xiaoyan Jia, Huan Zhao, Qiong Hu, Bing Yang, Dongxin Tang, Minyi Tian.  (2025)  Anti-Lung Cancer Effects and Related Mechanisms of α-Caryophyllene In Vitro and In Vivo.  Food Science & Nutrition,  13  (9): (e70862).  [PMID:40895140] [10.1002/fsn3.70862]

32. Jiaao Shen, Zijia Man, Weiwei Li, Mengqi Guo, Zefeng Xiang, Long Ma, Xianjiang Kang, Shuai Guo.  (2025)  Natural isoflavone sophoricoside emerges as a therapeutic candidate for lung cancer targeting TMEM16A ion channel.  PHYTOMEDICINE,      [PMID:41014666] [10.1016/j.phymed.2025.157289]

33. Xiong-Li Liu, Jing Lou, Xian-Qiao Zhu, Di-Cheng Pan, De-Wu Liu, Hui-Xian Jing, Wenjing Zhang, Hong-Xing Cen, Guo-Deng Guo-Deng Dong.  (2025)  Monodentate/bidentate chiral Ph/Py-NO ligands: an unexpected switch of enantioselectivity in Friedel-Crafts alkylation of indoles and 2,3-dioxopyrrolidines.  NEW JOURNAL OF CHEMISTRY,      [PMID:] [10.1039/D5NJ02472B]

34. Gaojian Liu, Wenjing Wen, Xuan Zhao, Yanan Jing, Hao Li, Xulong Fan, ZiXuan Huang, Gaofeng Liang.  (2025)  Enhanced ferroptosis by light-triggered biomimetic nano-erythrocyte membranes for tumor synergistic therapy.  NANOTECHNOLOGY,  36  (30): (305101).  [PMID:40697158] [10.1088/1361-6528/ade1de]

35. Kaiming Li, Ziming Lin, Ting Wu, Jintong Zhou, Jie Wu, Yupeng Zhou, Huimin Gao, Ya Lin, Xufeng Chen, Huae Xu, Xiaolin Li.  (2025)  Enhancing cisplatin therapy for small cell lung cancer via a dual strategy of combining surufatinib and CD47 blockade.  JOURNAL OF CONTROLLED RELEASE,      [PMID:41130421] [10.1016/j.jconrel.2025.114348]

36. Haoyu Yang, Xin Chen, Siqi Huang, Hongfang Dai, Zuowei Xiao, Jialong Fan, Honggang Zhang, Ke Du, Yan Qin.  (2025)  A novel GSH depletor for simultaneous ferroptosis and cuproptosis Activation in hepatocellular carcinoma.  BIOCHEMICAL PHARMACOLOGY,      [PMID:41173053] [10.1016/j.bcp.2025.117488]

37. Peinan Yin, Anamaria Brozovic, Wei Zhang, Chengwei Wu.  (2025)  Core–shell hydrogel microspheres with sequential drug release and magnetothermal synergy for drug-resistant ovarian cancer.  Biomaterials Science,      [PMID:41186349] [10.1039/D5BM01191D]

38. Xia Tian, Zheng Han, Ye Yu, Jie Tan, Qingxi Zhu, Wei Chen, Shasha Huang, Xiaoli Chen, Meng Liu.  (2025)  Silencing CDH17 reverses cisplatin resistance in gastric cancer cells by regulating the Warburg effect mediated by the Wnt/β-catenin pathway.  American Journal of Translational Research,  17  (10): (8060).  [PMID:41268259] [10.62347/MQKY6944]

39. Cheng Huang, Haowen Liu, Bao Jiang, Guoli Li, Xinlu Qin, Yinan Hua, Yongming Deng, Yicheng Wang, Lin Zhou.  (2025)  Electrochemical sensor for urinary H2O2 detection to aid AKI diagnosis and treatment evaluation.  BIOELECTROCHEMISTRY,      [PMID:41260111] [10.1016/j.bioelechem.2025.109173]

40. Simeng Xiao, Yun Zhao, Zhiguo Chen, Yangkun Xiong, Dingmei Zhang, Gang Zhou, Cong Zhang.  (2025)  Celastrol delays the progression of hepatocellular carcinoma by suppressing SLC1A5-mediated glutamine dependence.  TOXICOLOGY AND APPLIED PHARMACOLOGY,      [PMID:41401867] [10.1016/j.taap.2025.117690]

41. Wenhao Zhou, Yijie Cai, Xilei Wang, Yijun Tu, Jiejuan Jiang, Jianqing Yu.  (2025)  Optimized extraction, isolation and identification of bioactive sesquiterpenes from Inula racemosa.  BIOORGANIC CHEMISTRY,      [PMID:41447946] [10.1016/j.bioorg.2025.109423]

42. Xiaoli Deng, Chunjie Hu, Lin Li, Guixian Yang, Chikun Li, Wanxun Zhang, Guangyu Cheng.  (2025)  Study on mechanism of action of β-elemene in inhibiting cisplatin resistance in lung cancer through LncRNA LINC00511.  Frontiers in Pharmacology,      [PMID:41480385] [10.3389/fphar.2025.1586657]

43. Alfaiz Faiz Abdulaziz.  (2025)  Biofabrication of chitosan-loaded gold nanoparticles: investigation of antimicrobial and anticancer activity and its morphological assessment in liver cancer cells.  NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY,      [PMID:41454954] [10.1007/s00210-025-04922-1]

44. Wei Dong, Wanlin Xie, Kun Song, Qunying Yuan, Peiyu Xi, Haoqun Fan, Lele Ma, Weidi Sun, Hui Zhang, Weihong Tan.  (2025)  A Membrane-Retained DNA Aptamer Promotes Intracellular Platinum Accumulation and Chemosensitization in Ovarian Cancer.  ACS Applied Materials & Interfaces,      [PMID:41461381] [10.1021/acsami.5c16889]

45. Qixiang Fang, Chengyu You, Xi Xiao, Yang Liu, Weiguang Yang, Qingchao Li, Liangliang Qing, Zhilong Dong.  (2025)  Mevalonate Metabolic Reprogramming Drives Cisplatin Resistance in Bladder Cancer: Mechanisms and Therapeutic Targeting.  PROTEIN AND PEPTIDE LETTERS,  32  (8): (597-609).  [PMID:40916434] [10.2174/0109298665403178250806111943]

46. Jianfa Wu, Huang Chen, Sihong Wang, Lei Peng, Xiaoying Hu, Zhou Liu.  (2025)  miR-512-3p/RPS6KA2 Axis Regulates Cisplatin Resistance in Ovarian Cancer via Autophagy and Ferroptosis.  ONCOLOGY RESEARCH,  34  (1): (26).  [PMID:41502518] [10.32604/or.2025.070542]

47. Sai-Nan Qin, Yi-Xue Zhang, Yi-Jie Cao, Ting Wan, Yi-Yang Zhou, Shan-Shan Su, Yu-Qiong Guo, Jian-Jun Sun, Kalle Salminen.  (2026)  A self-assembled electrochemical aptasensor for one-step rapid detection of cisplatin in blood via aptamer conformational change.  MICROCHEMICAL JOURNAL,      [PMID:] [10.1016/j.microc.2026.116962]

48. Dong-Gui Guo, Lin-Lu Liu, Sijie Zhang, Hong-Xing Cen, Xiong-Li Liu, Hui-Juan Wang, Li-Jun Peng.  (2026)  Biomimetic synthesis of dispiro sesquiterpene lactone type of alkaloids and discovery of potential anticancer scaffolds.  NEW JOURNAL OF CHEMISTRY,      [PMID:] [10.1039/D5NJ04317D]

49. Bo Liu, Yaqin Tu, Xiangrui Li, Wenting Yu, Wenqing Zou, Wei Tang, Shimin Zong, Songwei Tan, Hongjun Xiao.  (2026)  Liposome-Encapsulated Rutin Attenuates Cisplatin-Induced Ototoxicity via Suppression of P53-Associated Oxidative Injury..  Biomaterials Research,      [PMID:41676218] [10.34133/bmr.0324]

50. Xiaoyi Cheng, Xiang-Fu Du, Jing Long, Yangyi Nie, Yuhan Du, Luyao Cheng, Cairong Li, Mei-Xia Zhao, Yuxiao Lai, Wei Zhang.  (2026)  Multifunctional cisplatin-loaded polydopamine/MnO2 nanomedicine circumvents drug resistant tumor microenvironment for enhanced chemo-photothermal therapy.  COLLOIDS AND SURFACES B-BIOINTERFACES,      [PMID:41666770] [10.1016/j.colsurfb.2026.115505]

51. Ke Li, Zhengxiang Wang, Zaigang Zhou, Huan Ding, Sheng Wu, Yuan Li, Jianliang Shen.  (2026)  Mitochondria-Targeting Nanocuproptosis Breaks Immune Resistance.  ADVANCED FUNCTIONAL MATERIALS,      [PMID:] [10.1002/adfm.202528750]

52. Haibo Wang, Yongbing Gu, Huifen Zhu, Xianlang Chen, Yanling He, Rongrong Li, Ansheng Yu, Chenli Xu, Xiaohe Zheng, Lei Shi.  (2026)  Design, synthesis and biological evaluation of novel substituted pyrazole-hydrazine hybrids as potent and safe anti-leukemia agents.  JOURNAL OF MOLECULAR STRUCTURE,      [PMID:] [10.1016/j.molstruc.2026.145702]

53. Meixin Wang, Shi Yang, Yifei Xu, Jianwei Wang, Yage Zhang, Qingming Ma, Chuanliang Feng, Yang Song.  (2026)  Nucleus-Localizing Coacervates Synergize with Chemotherapy for the Treatment of Drug-Resistant Ovarian Tumors.  BIOMACROMOLECULES,      [PMID:41728903] [10.1021/acs.biomac.5c02014]

54. Xiaomei Ye, Shuzhen Lu, Hao Peng, Zhirong Huang, Chunyu Pan, Yayan Huang, Kangrui Yuan, Youfa Qin.  (2026)  A pH-responsive mesoporous Zn-MOF nanocarrier for efficient cisplatin delivery and inhibition of A549 cancer cells.  JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE,  37  (1): (42).  [PMID:41739347] [10.1007/s10856-026-07022-5]

55. Gao Hengyuan, Lin Junqing, Chen Xiaobing, Su Yingshi, Huang Yibin, Zhang Yubo, Zhang Junchang, Xu Nan, Dai Xiaoyong.  (2026)  Microfluidic-based patient-derived organoids recapitulate thyroid cancer heterogeneity and reveal NF-κB-driven maturation for precision therapy.  Journal of Translational Medicine,      [PMID:41761289] [10.1186/s12967-026-07882-z]

56. Qiaomei Zheng, Xia Zhang, Shaozhan Chen, Shaoyu Wang, Lihong Chen, Jinhua Wang.  (2026)  Indirubin suppresses ovarian cancer progression by inhibiting PI3K/AKT-mediated EMT and tumor growth without systemic toxicity.  PHYTOMEDICINE,      [PMID:] [10.1016/j.phymed.2026.158045]

57. Jun-Hong Liu, Qian-Lian Yin, Xue Li, Mei Qing Zhang, Lin Guo Zou, Xin Jian Song, Li Jiang, Chun Hua Liu, Yong Jun Li.  (2026)  Isolation and biological evaluation of a novel steroid from Sagina japonica (Sw. ex Steud.) Ohwi.  NATURAL PRODUCT RESEARCH,      [PMID:] [10.1080/14786419.2026.2637148]